BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 4137067)

  • 1. Monoamine oxidase and cerebral uptake of dopaminergic drugs.
    Cotzias GC; Tang LC; Ginos JZ
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2715-9. PubMed ID: 4137067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Förster W; Gräbner S
    Acta Biol Med Ger; 1966; 16(6):650-7. PubMed ID: 4383660
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

  • 5. On the dopaminergic nature of the gnawing compulsion induced by apomorphine in mice.
    Fekete M; Kurti AM
    J Pharm Pharmacol; 1970 May; 22(5):377-9. PubMed ID: 4392998
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.
    Carlsson A; Lindqvist M; Waldeck B
    Eur J Pharmacol; 1968 Apr; 3(1):34-9. PubMed ID: 5654667
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 8. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
    Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
    Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):83-98. PubMed ID: 4280020
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine oxidase in adult Hymenolepis diminuta (Cestoda).
    Moreno MS; Barrett J
    Parasitology; 1979 Feb; 78(1):1-5. PubMed ID: 419001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the functional role of intraneuronal monamine oxidase.
    Clarke DE; Sampath SS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):539-49. PubMed ID: 4770399
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of catecholamines, adrenergic substances and their blocking agents on the searching behavior of mice.
    Fischer E; Saavedra JM; Heller B
    Arzneimittelforschung; 1968 Jul; 18(7):780-6. PubMed ID: 5755819
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
    Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
    Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 17. Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by arcuato-infundibular neurons.
    Lichtensteiger W; Langemann H
    J Pharmacol Exp Ther; 1966 Mar; 151(3):400-8. PubMed ID: 5938477
    [No Abstract]   [Full Text] [Related]  

  • 18. Locomotor response of nialamide pretreated old rats to intraaccumbens dopamine.
    Cousin KM; Uretsky NJ; Gerald MC
    Pharmacol Biochem Behav; 1985 Mar; 22(3):461-8. PubMed ID: 3991761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome.
    Modigh K; Svensson TH
    Br J Pharmacol; 1972 Sep; 46(1):32-45. PubMed ID: 4263796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.